Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Schering AG (NYSE:SHR)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs
Location
Muellerstrasse 178
13353 Berlin, Germany
Phone: (973) 276-2164
Fax: (973) 276-2005
Email: investor.relations@schering.de
Employees (last reported count): 23,720
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Major Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 22%
·Institutional: 0% (0% of float)
(19 institutions)
·Net Inst. Selling: 6,000  shares (+1.90%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Schering AG is a global research-based company engaged in the discovery, development, manufacture, marketing and sale of pharmaceutical products. The Company operates nine research and development centers in Europe, the United States and Japan; produces products in over 20 facilities located in Europe, United States, Latin America and Asia; and markets and sells its products in over 100 countries worldwide. The Company's focused product portfolio is comprised of products from its four core business areas: Fertility Control and Hormone Therapy, Therapeutics for selected disabling and life-threatening conditions, Diagnostic and Radiopharmaceuticals and Dermatology. The Company also participates in the crop protection and crop production business. The Company manages its businesses on a geographic basis, and its pharmaceutical business consists of five geographic segments: Europe, the United States, Latin America/Canada, Japan and Asia.
More from Market Guide: Expanded Business Description

Financial Summary
Schering AG is a global research-based company engaged in the discovery, development, manufacture, sale and marketing of pharmaceutical products primarily concentrated on the exploitation of novel technologies for unmet medical needs. For the six months ended 6/30/01, revenues rose 9% to EUR2.41 billion. Net income rose 26% to EUR264M. Revenues reflect acquisitions. Higher income also reflects higher income from Aventis CropScience.
More from Market Guide: Significant Developments

Officers

Position
Giuseppe Vita, 65Chairman of the Supervisory Board
Hubertus Erlen, 57CEO
Norbert Deutschmann, 49Vice Chairman of the Supervisory Board
Jurgen Wingefeld, 57Vice Chairman of the Supervisory Board
Ulrich Kostlin, 48Member of the Exec. Board
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:SHRAs of 31-Aug-2001
Price and Volume
52-Week Low
on 16-Mar-2001
$45.70 
Recent Price$52.15 
52-Week High
on 14-June-2001
$56.45 
Daily Volume (3-month avg)4,955 
Daily Volume (10-day avg)2,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
26-Week Change-0.3%
26-Week Change
relative to S&P500
+8.6%
Share-Related Items
Market Capitalization$10.3B
Shares Outstanding197.8M
Float154.3M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$11.51 
Earnings (ttm)$1.79 
Earnings (mrq)$0.63 
Sales (ttm)$21.41 
Cash (mrq)$2.42 
Valuation Ratios
Price/Book (mrq)4.53 
Price/Earnings (ttm)29.15 
Price/Sales (ttm)2.44 
Income Statements
Sales (ttm)$4.26B
EBITDA (ttm)$586.0M
Income available to common (ttm)$355.8M
Profitability
Profit Margin (ttm)8.6%
Operating Margin (ttm)13.7%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)7.64%
Return on Equity (ttm)16.60%
Financial Strength
Current Ratio (mrq)2.39 
Debt/Equity (mrq)0 
Total Cash (mrq)$479.6M
Short Interest
As of 8-Aug-2001
Shares Short88.0K
Percent of Float0.1%
Shares Short
(Prior Month)
64.0K
Short Ratio17.60 
Daily Volume5,000 
ADR Information
Shares/ADR1
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001);   dollar amounts based on an exchange rate of 1.1 Euro/Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.